Dr. Reddys Laboratories

4160.75

+49.05 (1.19%)

BSE

Buy Sell

NSE BSE

Last updated on 26 Apr 2022 1:55 PM

Invest in Stocks for FREE*

Invest and trade in your favourite companies

Open Demat account

Returns

-1.24%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

68429.4

Earning Per Share

131.39

Dividend Yield

0.55%

P/E Ratio

34.37

P/B Ratio

3.92

Debt to Equity

0.08

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations. The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr.

Similar Companies

Sun Pharmaceutical

915.7 +15.70 (0.02%)

1Yr Returns

+41.79%

Cipla

978.35 +25.20 (0.03%)

1Yr Returns

+5.27%

Torrent Pharmaceuticals

2717.85 -14.45 (-0.01%)

1Yr Returns

+8.79%

Alkem Laboratories

3308.75 -2.20 (-0.00%)

1Yr Returns

+18.33%

Aurobindo Pharma

638.05 -0.85 (-0.00%)

1Yr Returns

-34.21%